Final Generic Abuse-Deterrent Opioids Guidance Coming This Year
US FDA says it expects to finalize guidance by November, but more research is needed with generic development questions lingering.
US FDA says it expects to finalize guidance by November, but more research is needed with generic development questions lingering.